Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.

Ilari M RautalinMartina SebökMenno R GermansMiikka KorjaNoemi DanneckerOlivia Zindel-GeisselerPeter BruggerLuca RegliMartin N Stienen

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2019)

The two screening tools implemented here frequently identified NPDs among aSAH patients that were categorized with favorable outcome according to the mRS. Our results suggest that MoCA or ERFC could be used to screen early NPDs in favorable outcome patients, who in turn might benefit from early neuropsychological rehabilitation.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
high throughput
fluorescent probe
living cells
single cell
patient reported